The landscape of dementia prognosis has evolved significantly with the arrival of advanced biomarkers, which include amyloid PET scans, tau imaging, and blood-based exams which can detect Alzheimer's pathology many years in advance of symptoms emerge. Even though these technological innovations represent exceptional development in being familiar wi